ID: ALA4749933

Max Phase: Preclinical

Molecular Formula: C29H28FNO2

Molecular Weight: 441.55

Molecule Type: Unknown

Representations

Canonical SMILES:  CC1(C)C=Cc2c(c(C=O)cc3c4cc(C(C)(C)C)ccc4n(Cc4cccc(F)c4)c23)O1

Standard InChI:  InChI=1S/C29H28FNO2/c1-28(2,3)20-9-10-25-23(15-20)24-14-19(17-32)27-22(11-12-29(4,5)33-27)26(24)31(25)16-18-7-6-8-21(30)13-18/h6-15,17H,16H2,1-5H3

Standard InChI Key:  RUWJYHQOFRCORQ-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 441.55

Molecular Weight (Monoisotopic): 441.2104

AlogP: 7.28

#Rotatable Bonds: 3

Polar Surface Area: 31.23

Molecular Species: NEUTRAL

HBA: 3

HBD: 0

#RO5 Violations: 1

HBA (Lipinski): 3

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 1

CX Acidic pKa:

CX Basic pKa:

CX LogP: 7.34

CX LogD: 7.34

Aromatic Rings: 4

Heavy Atoms: 33

QED Weighted: 0.31

Np Likeness Score: 0.19

References

1. Liu K,Zang Y,Shen C,Li C,Ma J,Yang J,Sun X,Chen X,Wang N,Zhang D.  (2021)  Synthesis and biological evaluation of pyranocarbazole derivatives as Anti-tumor agents.,  33  [PMID:33316408] [10.1016/j.bmcl.2020.127739]

Source

Source(1):

• Scientific Literature